Cellectis
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Cellectis and buy or sell other stocks, ETFs, and their options commission-free!About CLLS
Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J.
CEOAndré Choulika
CEOAndré Choulika
Employees222
Employees222
HeadquartersParis, Ile-de-France
HeadquartersParis, Ile-de-France
Founded1999
Founded1999
Employees222
Employees222
CLLS Key Statistics
Market cap191.51M
Market cap191.51M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume63.47K
Average volume63.47K
High today$2.68
High today$2.68
Low today$2.57
Low today$2.57
Open price$2.63
Open price$2.63
Volume35.02K
Volume35.02K
52 Week high$3.24
52 Week high$3.24
52 Week low$1.10
52 Week low$1.10
Analyst ratings
75%
of 8 ratingsBuy
75%
Hold
25%
Sell
0%